Two Sigma Advisers’s Amgen AMGN Stock Holding History

Two Sigma Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-8,000	Closed	-$1.12M	–	2411
2014 Q3	$1.12M	Sell	8,000 -47,000	-85%	-$6.14M	0.01%	1073
2014 Q2	$6.51M	Buy	55,000 +47,000	+588%	+$5.44M	0.05%	396
2014 Q1	$987K	Sell	8,000 -4,000	-33%	-$485K	0.01%	1165
2013 Q4	$1.37M	Sell	12,000 -4,000	-25%	-$455K	0.01%	964
2013 Q3	$1.79M	Sell	16,000 -20,000	-56%	-$2.17M	0.02%	688
2013 Q2	$3.55M	Buy	+36,000	New	+$3.74M	0.05%	323

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Two Sigma Advisers's AMGN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Amgen (AMGN) in Q1 2026, closing a stake of 735,880 shares — an estimated $241M sold.

Two Sigma Advisers first reported a position in AMGN in Q4 2013 and held it in 48 quarters. The position peaked at $491M in Q2 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Two Sigma Advisers reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 735,880 Amgen shares in Q1 2026, an estimated $241M.
Two Sigma Advisers first reported a position in Amgen in Q4 2013 and held it in 48 quarters.
Two Sigma Advisers's Amgen position peaked at $491M in Q2 2019.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.